Page 231 - Read Online
P. 231

Menon et al.                                                                                                                                                 Pediatric anti-GAD antibody mediated encephalitis























           Figure 2: (A) FLAIR axial image; (B) T2-Weighted axial image. FLAIR and T2W axial MRI sequences in case 2 demonstrating global
           atrophy with loss of grey white matter differentiation over the left posterior quadrant. This was done 1 month after the first episode of
           complex partial status epilepticus. FLAIR: fluid attenuated inversion recovery; T2W: T2-weighted; MRI: magnetic resonance imaging

           clinical presentations of presumed GAD mediated    has been demonstrated with ampiphysin antibodies
           autoimmunity in the pediatric age-group. Despite the   associated with paraneoplastic SPS.  A more plausible
                                                                                              [8]
           inability to ascertain intrathecal synthesis of GAD-ab,   explanation is that other unknown antibodies in sera
           treatment was directed by clinical suspicion of the same   positive for GAD-ab are the pathogenic moiety;
           and subsequent responses. Sero-prevalence of GAD-ab   the possible co-existence of antibodies for other
           raises controversies on its role in CNS autoimmunity.   membrane antigens, i.e. GABA-B receptor and glycine
           GAD is the rate limiting enzymein the formation of   receptor requires further evaluation. [9,10]   Furthermore,
           inhibitory neurotransmitter GABA. The enzyme has 2   GAD-ab titers are significantly higher in the sera of adult
           isoforms-GAD 65 and GAD 67, which differ substantially   patients  with CNS  involvement,  some  of  whom  also
           in their amino terminal,  but function in synergy to   have evidence of intrathecal synthesis.  Due to lack
                                                                                                 [2]
           maintain  a  physiological  GABA  level,  with  the  former   of availability we could not confirm the antibody status
           more active during stress and the latter assuming more   using cell-based assays.  There is enough evidence
           of a housekeeping function.  GAD 65 is an intracellular   in literature that the epitopes of classical intracellular
                                   [5]
           protein, but it has been suggested that it could be   or onconeuronal antigens (Hu,  Yo, Ri, CRMP5, Ma2,
           exposed on the cell surface during exocytosis from   amphiphysin)  are  resistant  to  protein  denaturation,
           GABA-ergic neurons, allowing a pathogenic ab-antigen   and hence detectable by immunoblot or ELISA, as
           interaction  to  occur.  GAD  65-specific  autoantibodies   well as immunohistochemistry using mammalian brain,
           are also seen in some patients with other neurologic   most commonly rat or mouse.  This is contrasted to
                                                                                         [11]
           diseases,  such  as  myoclonus,  stiff  person  syndrome,   antibodies to cell surface or synaptic protein ssuch as
           pure cerebellar ataxia. [2,5]  High GAD-ab levels, usually   those against NMDA and VGKC wherein the reactivity is
           more than 100-fold higher that those found in DM1,   usually lost when the antigen is denatured so that these
           are present in up to 80% of patients with stiff person   antibodies cannot be detected by standard immunoblot
           syndrome (SPS), a subgroup of patients with late   or ELISA. Detection of these antibodies requires either
           onset isolated cerebellar ataxia, epilepsy or brain stem   an immunohistochemistry protocol adapted to cell
           dysfunction and are usually associated with type 1   surface antigens, the use of cultures of live neurons,
           diabetes or poly-endocrine autoimmunity, both of which   or cell-based assays in which recombinant antigens
           were not seen in our patients. [6]                 are expressed in mammalian cells. It is evident that
                                                              the  specificity  and  sensitivity  of  these  assays  vary
           The causative immunological mechanisms remain      among laboratories even when the same techniques
           speculative at best, and the clinical spectrum of GAD-  are used. Because the reading of the tests is done
           ab  associated  disease  may  depend  on  the  specific   by visual assessment, the interpretation of low serum
           immunological  response  that  is  elicited.  While  it  is   titers can be misleading, and some sera produce non-
           believed that GAD-ab are unlikely to be pathogenic, in   specific background reactivity that may be interpreted
           vitro studies suggest that IgG from patients can mediate   as a positive result, although this rarely occurs when
           effects on cerebellar neurons. [3,7]  One explanation   CSF  is  used.  Another  study  however  demonstrated
           could be the intracellular uptake of these antibodies   absence of serum cross reactivity to NMDA and VGKC
           with  subsequent  inhibition  of  GABA  synthesis,  as   antibody in patients with suspected anti GAD mediated
            222                                                                Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ September 28, 2016
   226   227   228   229   230   231   232   233   234   235   236